th global experts meeting on neuropharmacology · 2018-12-27 · studies on neuronal circuits...
TRANSCRIPT
NeuropharmacologyNovember 18-19, 2019
Rome, Italy
27th Global Experts Meeting on
S C I E N T I F I C P R O G R A M
conferenceseries.com
SCIENTIFIC PROGRAM
Monday 18th November DAY 1Monday 18th November
08:30-09:00 Registrations
09:00-09:30 Introduction
09:30-09:50 COFFEE BREAK
09:50-11:50 Meeting Hall 01
KEYNOTE LECTURES
MEETING HALL 01 MEETING HALL 02
11:50-13:10 Talks On: Clinical Neuropharmacology
Talks On: Neuroimmunology and Neuroinflammation
Clinical neuropharmacology of drug abuse Cortical systems and their complexicity
Clinical neuropharmacology and therapeutics Epilepsy and epileptic seizures
Clinical neuropharmacology of pain Immunopathogenesis of brain tumour
Clinical neuropharmacology of hypothalamic releasing factors Brain Injury and Stroke
13:10-13:15 GROUP PHOTO
13:15-14:00 LUNCH BREAK
MEETING HALL 01 MEETING HALL 02
14:00-16:00 Talks On: Molecular Neuropharmacology Talks On: Parkinson’s Disease
Neurogenesis and repair Impact of genetic mutations
Studies on neuronal circuits Interdependent disorders such as neurodegenerative disorders and ageing
Manipulation of ion channels by drugs Anxiety, depression and stress level in Parkinson’s
Animal cognition and behaviour - Fear and aversive learning and memory Approaches involved in diagnostics
GABA , 5HT receptors and its neuronal development Drug desigining and therapeutics
16:00-16:20 COFFEE BREAK
MEETING HALL 01 (16:20-17:00) MEETING HALL 01 (17:00-18:00)
Young Researchers in Neuropharmacology
Workshop
Visit: http://neuro.pharmaceuticalconferences.com
SCIENTIFIC PROGRAM
Tuesday, 19th November DAY 2Tuesday, 19th November
09:00-10:30 Meeting Hall 01
KEYNOTE LECTURES
10:30-10:50 COFFEE BREAK
MEETING HALL 01 MEETING HALL 02
10:50-12:50 Talks On: Alzheimer’s Disease and Dementia
Talks On: Psychopharmacology
Molecular diagnostics Preclinical psychopharmacology
Symptoms, causes and diagnostics Clinical and translational psychopharmacology
Neurocognitive effects associated with therapeutic drugs
Psychopharmacology drugs and their interaction with neurotransmitters
Environmental effects associated with disease
Dose response relation in psychiatric medications
Role of amyloid protein in Alzheimer Effect of androgenic anabolic steroids on psychosis
12:50-13:35 LUNCH BREAK
MEETING HALL 01 MEETING HALL 02
13:35-15:55 Talks On: Neural Stem Cell
Talks On: Neuroethics
Stem cell isolation techniques Neurological disorders and implications for society
Application in treatment Neurological disorders and implications for society
Problems associated in therapy Neuroethics of neurological treatements and management
Ethical issues associated 4Neuroethics associated with different stages of conciousness and related disorders
Stem cells in various Brain injury Addiction neuroethics
15:55-16:15 COFFEE BREAK
MEETING HALL 01 (16:15-17:00) MEETING HALL 01 (17:00-18:00)
Poster Presentations Workshop
Visit: https://neuro.pharmaceuticalconferences.com/
Istvan Berczi University of Manitoba, Canada
Harish C Pant National Institutes of Health, USA
Hari Shanker Sharma Uppsala University, Sweden
Jan Ulfberg Capio Sleep Center, Sweden
Michael V Ugrumov Institute of Developmental Biology RAS, Russia
David Truswell Somefreshthinking Consultancy, UK
Varghese John University of California, USA
Stephen D Skaper University of Padua, Italy
Joel B Schachter Merck Research Laboratories, USA
Mariya Hristova University College London, UK
Saule T Turuspekova KazNMU, Kazakhstan
Yacov Rofé Bar-Ilan University, Israel
Arieh S Solomon Tel Aviv University, Israel
Alireza Rezayi Shahid Beheshti University of Medical Sciences, Iran
Ying-Chieh Tsai National Yang-Ming University, Taiwan
Maha Nada Ain Shams University, Egypt
M Cohen-Armon Tel-Aviv University, Israel
Hala Fakhiry Cairo University, Egypt
James B Ames University of California, USA
Thomas Rich University of South Alabama, USA
Saravanan Kolandaivelu West Virginia University Eye Institute, USA
Frans Vinberg Washington University School of Medicine, USA
Teresa Duda Salus University, USA
Clint L Makino Boston University, USA
PAST AFFILIATESPA
ST A
FFIL
IATE
S
Visit: https://neuro.pharmaceuticalconferences.com/
Ana Méndez University of Barcelona, Spain
Jose F Abisambra University of Kentucky, USA
Boris Tchernychev Ironwood Pharmaceuticals Inc., USA
Elangovan Vellaichamy University of Madras, India
Ichiro N Maruyama Okinawa Institute of Science and Technology, Japan
Magnus S Magnusson University of Iceland, Iceland
Nicolas Marie Neuroplasticity and Therapies of Addictions, France
Cristina Vittoria Dieni University of Perugia, Italy
José R Sotelo Instituto de Investigaciones Biológicas Clemente Estable, USA
Kailash N Pandey Tulane University, USA
Xavier F Figueroa Pontificia Universidad Catolica de Chile, Chile
Stephanie C Joachim University Eye Hospital, Germany
Anna Puigdellívol-Sánchez University of Barcelona, Spain
Ahmed K Salama Majmaah University, Saudi Arabia
Masaraf Hussain North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, India
Georgianna G Gould The University of Texas, USA
Enzo Wanke University of Milano-Bicocca, Italy
Mark W Burke Howard University, USA
Hua Su University of California, USA
Kazue Takayanagi Seiwaen Geriatric Institute, Japan
Takashi Kitajima ONO Pharmaceutical Co., LTD, Japan
Thomas Grund University of Regensburg, Germany
PAST AFFILIATESPA
ST A
FFIL
IATE
S
Visit: https://neuro.pharmaceuticalconferences.com/
PAST AFFILIATESHua P Su MSD Research Labs, USA
Giuseppe Scalabrino University of Milan, Italy
Hideo Tsukada Hamamatsu Photonics K.K., Japan
Maria Lindau Stockholm University, Sweden
Marina Zueva Moscow Helmholtz Research Institute of Eye Diseases, Russia
Patrizia LoPresti University of Illinois at Chicago, USA
Michel CYR University of Trois-Rivieres, Canada
Gjumrakch Aliev GALLY International Biomedical Research Institute Inc., USA
Donard S Dwyer LSU Health Sciences Center, USA
Oscar Bernal-Pacheco Instituto Roosevelt, Canada
Nachum Dafny The University of Texas, USA
Rameshwar K Sharma Salus University, USA
Keith Pennypacker University of Kentucky, USA
Saobo Lei University of North Dakota, USA
Kjell Fuxe Karolinska Institutet, Sweden
Elizabeth K Barber Barber Innovations LLC, USA”
Anita N Datta University of British Columbia, Canada
PAST
AFF
ILIA
TES
Visit: https://neuro.pharmaceuticalconferences.com/
Glimpses of Neuropharmacology
Rome Attractions
Baths
of C
arac
alla
Colosseum
Vatic
an C
ity
San
Giova
nni i
n
Late
rano
Foro
di T
raia
-
no
Trev
i Fou
ntai
n
The
Pant
heon
Pala
tine
Hill
Piaz
za N
avon
a
Neuropharmacology 2019• Neurochemistry & Neuropharmacology: Open Access
• Journal of Neurological Disorders
• Journal of Neurology & Neurophysiology
Important Dates
Abstract submission opens: December 03, 2018
Registration opens: December 03, 2018
On spot registration: November 18, 2019
Contact Us
Program Manager
Neuropharmacology 2019
Pharma Conferences
47 Churchfield Road, London, W3 6AY
W: http://neuro.pharmaceuticalconferences.com
Phone:+448000148923
Venue & Accommodation
Rome, Italy
Visit: https://neuro.pharmaceuticalconferences.com/